Photo of Naveen Bellam, MD

Naveen Bellam, MD

Transplant Cardiologist

Expertise of Naveen Bellam, MD

6 items. To interact with these items, press Control-Option-Shift-Right Arrow
Item 1 of 6
Biography

Dr. Bellam is trained to care for patients requiring treatment for end-stage heart failure with the possibility of needing heart transplantation. His clinical specialties include management of patients with end-stage heart failure, cardiogenic shock, mechanical circulatory support (VAD), pulmonary hypertension, ventricular assist devices, and heart transplantation. Dr. Bellam sees patients both pre- and post-transplant to ensure they receive the best care and healing possible. His research has focused on risk stratification and improving disease management in patients with cardiovascular disease and heart failure. He has presented multiple publications locally and internationally. He is board-certified in Internal Medicine, Cardiovascular Disease, and Echocardiography. Dr. Bellam is a member of the American College of Cardiology (ACC), International Society of Heart and Lung Transplantation (ISHLT), and the Heart Failure Society of America (HFSA).

Item 2 of 6
Education

Joan C. Edwards School of Medicine at Marshall University

Item 3 of 6
Residency

Emory University Hospital; Emory University

Item 4 of 6
Fellowship

University of California, Los Angeles (UCLA)

Item 5 of 6
Specialty

Cardiology; Echocardiography

Item 6 of 6
Board Certifications

American Board of Internal Medicine

Publications of Naveen Bellam, MD

Associated Clinical Trials for Naveen Bellam, MD

  • NCT03142152

    Assessment of the Carillon Mitral Contour System in Treating Heart Failure with Functional Mitral Regurgitation

    This study is currently enrolling.
    Associated Conditions: Heart
    Research Area: Transplant Research
    Research Location: Orlando

    The purpose of this clinical study is to evaluate the safety and effectiveness of the Carillon Mitral Contour System in people who have mitral regurgitation resulting from heart failure.


  • NCT05258942

    MyLeukoMAP Genomic Survival Prediction Assay

    This study is not currently enrolling.
    Associated Conditions: Heart
    Research Area: Transplant Research
    Research Location: Orlando

    Heart failure (HF) can cause other organs to shut down. This process appears to involve the white blood cells of the immune system. Our data show that abnormal gene activation or suppression of white...

    More clinical trials loaded